download
print
% Change:
Volume:
52-Week High:
52-Week Low:

EVENTS & PRESENTATIONS

Alnylam TTR Investor Webinar

Past Events ›

46th Annual TD Cowen Healthcare Conference

Past Events ›

Alnylam Pharmaceuticals Q4/FY 2025 Earnings Conference Call

Past Events ›

View all events and presentations ›
container-970 d-flex flex-1

2025 Annual Report

Download

2024 Corporate Responsibility Report

Download

capella

Investor & Scientific Presentations

Explore Capella ›

Investor Toolkit

Quarterly Earnings Presentation - Icon

Q4 & Full-Year 2025 Earnings Presentation VIEW PDF ›

10-K - Icon

Latest Form 10-K VIEW PDF ›

10-Q - Icon

Latest Form10-Q VIEW PDF ›

sec-icon

SEC
Filings VIEW All ›

sec-icon

2026 Proxy Statement LEARN MORE ›

View all resources and documents ›

Discover Our Commitment to Patients, Employees, and Our Communities

Corporate Responsibility ›

PRESS RELEASES

Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial Results

Learn More ›

New Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management

Learn More ›

Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association

Learn More ›

View all press releases ›